HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

SB 331750

a cathepsin K inhibitor; structure in first source
Also Known As:
5-(2-morpholin-4-yl-ethoxy)-benzofuran-2-carboxylic acid ((S)-3-methyl-1-(3-oxo-1-(2-(3-pyridin-2-yl-phenyl)-ethenoyl)-azepan-4-ylcarbanoyl)-butyl)-amide; SB-331750; SB331750
Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Capper-Spudich, Elizabeth A: 1 article (06/2008)
2. Marquis, Robert W: 1 article (06/2008)
3. Locastro, Stephen M: 1 article (06/2008)
4. Long, Edward: 1 article (06/2008)
5. Podolin, Patricia L: 1 article (06/2008)
6. Fox, Josephine H: 1 article (06/2008)
7. Carpenter, Donald C: 1 article (06/2008)
8. McQueney, Michael S: 1 article (06/2008)
9. Dong, Xiaoyang: 1 article (06/2008)
10. Peterson, John J: 1 article (06/2008)

Related Diseases

1. Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
2. Experimental Arthritis
3. Bone Resorption
4. Hypercalcemia (Milk Alkali Syndrome)

Related Drugs and Biologics

1. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
2. Collagen
3. Cathepsin K
4. Parathyroid Hormone (Parathormone)
5. Cathepsins

Related Therapies and Procedures

1. Ovariectomy (Oophorectomy)